- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02408510
Pilot Project to Examine the Effects of Exercise on Nocturnal Lipolysis in Men and Women
Descripción general del estudio
Estado
Condiciones
Descripción detallada
This primary goal of this pilot project is to obtain preliminary data demonstrating the feasibility of measuring lipolysis and fat oxidation during sleep in adult human subjects using microdialysis, stable isotope labeling techniques, and whole-room indirect calorimetry. The results of this study will be used in grant applications to perform definitive studies using these methods. The long term goal of this line of research is to explore the mechanisms responsible for sex based differences in the effectiveness of physical activity as an approach to weight loss. Previous longitudinal data have shown that in normal weight and obese individuals, for any given increase in physical activity, there is a significantly greater loss of fat mass in men relative to women [Westerterp, 1997]. These data need to be reconciled, however, with the wealth of data demonstrating that during exercise, women release and oxidize fat more readily than men [Horton, 2009; Horton 1998, Moro 2007]. This phenomenon seems counterintuitive, given that men have less body fat than women and are able to lose more body fat than women when beginning a weight loss program [Bjorntorp, 2007]. Recent data suggests a mechanism to explain this paradox. Specifically, in obese subjects, 24-hour fat oxidation increased following a daytime bout of exercise, and this increase occurred in men only and was driven by a significant increase in fat oxidation not during the day but rather during sleep the night following exercise [Bergouignan, 2014]. Since the predominant source of fuel during sleep is free fatty acids (FFA) released from adipose tissue (i.e., lipolysis), it may be that enhanced sleeping lipolysis is a key factor in how exercise stimulates fat oxidation and thus greater fat loss in males vs. females over time.
The primary objective of the proposed study is to demonstrate the feasibility of measuring nocturnal whole-body and regional lipolysis by using stable isotope techniques and microdialysis of subcutaneous abdominal adipose tissue respectively with the long term goal of determining the effects of acute exercise during the daytime on rates of lipolysis at night in men and women. A secondary objective of this study is to determine if nocturnal regional lipolysis measured by microdialysis of subcutaneous abdominal adipose tissue and whole body lipolysis measured by a stable glycerol isotope infusion are related to dietary and whole body fat oxidation measured by stable isotope labelled fatty acid and whole-room calorimetry, respectively. Finally, the study aims to determine if sleep quality parameters measured by EEG and wrist actigraphy correlate with measures of nocturnal fat oxidation and lipolysis (regional and whole body)
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Colorado
-
Aurora, Colorado, Estados Unidos, 80045
- University of Colorado Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Males and Females, 20-35 years of age
- Sedentary (planned exercise < 3 d/week, < 30 min/session)
- Lifetime maximum BMI of 30 kg/m2
- Weight stable by self-report for at least 2 mo before the study (<5% weight change)
- Habitual sleeping pattern of >7 hours not to exceed 9.25 hours of sleep per night
- Zero to low-moderate caffeine intake (not to exceed 500 mg/d)
- Alcohol use fewer than two standard drinks per day per week for males and one or less drinks per day per week for females.
Exclusion Criteria:
- Current smoker
- Use of any medication that could affect lipid metabolism, insulin signaling, or sleep
- Pregnant women will not be enrolled in the study
- Current or chronic medical/psychiatric conditions
- Shift work or dwelling below Denver altitude (1,600 m) a year prior to testing
- Travel across more than one time zone 3 wk before study
- Abnormal eating patterns identified by interview and eating questionnaire
- Screening positive for illicit drugs
- Chronic health conditions such as diabetes,
- Hyper or hypothyroidism
- Sleep apnea (Apnea-Hypopnea Index >5)
- Renal or liver disease, anemia, or cancer
- Regularly go to sleep after midnight
One or more of the following out-of-range values measured on a fasting blood sample:
- glucose > 110 mg/dl,
- thyroid stimulating hormone <0.5 or >5.0 uU/ml,
- hemoglobin < 14.5 g/dl men, <12.3 g/dl women,
- alanine amino transferase > 47 U/l,
- aspartate aminotransferase > 47 U/l,
- alkaline phosphatase <39 or >117 U/l, or
- creatinine >1.1 mg/dl.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Change in Lipolysis
Periodo de tiempo: Overnight (2200h-0700h)
|
Measured using stable isotope tracers and microdialysis
|
Overnight (2200h-0700h)
|
Change in Substrate Oxidation
Periodo de tiempo: 24 hours
|
Measured using whole-room calorimetry
|
24 hours
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Change in Sleep Quality
Periodo de tiempo: Overnight (2200h-0700h)
|
Measured using wrist actigraphy
|
Overnight (2200h-0700h)
|
Change in Lipolytic Hormones
Periodo de tiempo: Overnight (2200h-0700h)
|
Frequent blood sampling to measure growth hormone, cortisol, catecholamines, and other lipolytic hormones
|
Overnight (2200h-0700h)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Daniel Bessesen, MD, University of Colorado, Denver
Publicaciones y enlaces útiles
Publicaciones Generales
- Westerterp KR, Goran MI. Relationship between physical activity related energy expenditure and body composition: a gender difference. Int J Obes Relat Metab Disord. 1997 Mar;21(3):184-8. doi: 10.1038/sj.ijo.0800385.
- Horton TJ, Dow S, Armstrong M, Donahoo WT. Greater systemic lipolysis in women compared with men during moderate-dose infusion of epinephrine and/or norepinephrine. J Appl Physiol (1985). 2009 Jul;107(1):200-10. doi: 10.1152/japplphysiol.90812.2008. Epub 2009 Apr 30.
- Horton TJ, Pagliassotti MJ, Hobbs K, Hill JO. Fuel metabolism in men and women during and after long-duration exercise. J Appl Physiol (1985). 1998 Nov;85(5):1823-32. doi: 10.1152/jappl.1998.85.5.1823.
- Moro C, Pillard F, de Glisezinski I, Crampes F, Thalamas C, Harant I, Marques MA, Lafontan M, Berlan M. Sex differences in lipolysis-regulating mechanisms in overweight subjects: effect of exercise intensity. Obesity (Silver Spring). 2007 Sep;15(9):2245-55. doi: 10.1038/oby.2007.267.
- Bjorntorp PA. Sex differences in the regulation of energy balance with exercise. Am J Clin Nutr. 1989 May;49(5 Suppl):958-61. doi: 10.1093/ajcn/49.5.958. No abstract available.
- Bergouignan A, Kealey EH, Schmidt SL, Jackman MR, Bessesen DH. Twenty-four hour total and dietary fat oxidation in lean, obese and reduced-obese adults with and without a bout of exercise. PLoS One. 2014 Apr 8;9(4):e94181. doi: 10.1371/journal.pone.0094181. eCollection 2014.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 13-0359
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .